October 16, 2025 · Form 4 insider transaction
GOLDSMITH MARK A bought 10,000 shares of Revolution Medicines, Inc. at $1.12 per share, a transaction worth $11.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 193,475 restricted stock units.